Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Pathophysiology and Pharmacology of Erythropoietin -

Pathophysiology and Pharmacology of Erythropoietin

Buch | Softcover
XVI, 328 Seiten
2011 | 1. Softcover reprint of the original 1st ed. 1992
Springer Berlin (Verlag)
978-3-642-77076-0 (ISBN)
CHF 149,75 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
I am honored to be invited to prepare a foreword for the proceedings of the Second International Lubeck Conference on Erythropoietin (Epo). I congratulate Wolfgang Jelkmann, Horst Pagel and Christoph Weiss for their organization of an excellent program for this conference which updated all of us on the advances made in erythropoietin research during the past few years since the first conference in June of 1988. I am sure that Professor Paul Carnot, had he been present at this conference, would be very pleased and proud of the advances made in the field of erythropoietin since his and Madame DeFlandre's seminal finding in 1906 (1) that rabbits produced a humoral substance following bleeding which controls red blood cell production. The reports by Hjort in 1936 (2) and by Erslev in 1953 (3) that large volumes of plasma or serum from rabbits following a bleeding stimulus, when injected into normal donor rabbits, produced a reticulocytosis, were very significant in confirming the existence of a humoral factor which controls erythropoiesis. Reissmann's parabiotic rat experiments in 1950 (4) reawakened interest in erythropoietin when he proved that hypoxia stimulated the production of a factor which regulates red cell produc tion. The studies of several investigators such as Jacobson et al. (5), Fisher and Birdwell (6), Kuratowska et al. (7) and Nathan et al.

List of Contents.- I. Structure and Action.- Structure-Function Relationships of Erythropoietin.- Isoforms of Recombinant Human Erythropoietin.- Activation of the Erythropoietin Receptor in the T3C12 Friend Erythroleukemia Cell Line.- II. Sites and Control of Production.- The Role of Adenosine in Hypoxic Regulation of Kidney Production of Erythropoietin.- Oxygen Shunt Diffusion in Renal Cortex and Its Physiological Link to Erythropoietin Production.- Oxygen Sensing and Erythropoietin mRNA Production in Isolated Perfused Rat Kidneys.- Analysis of Erythropoietin Gene Expression by Means of Competitive Polymerase Chain Reaction.- The Developmental Biology of Erythropoiesis and Erythropoietin: Is Erythropoietin a True Hormone or a Paracrine Factor.- Insulin-like Growth Factor 1 and Erythropoiesis During Growth.- III. Blood Levels in Health and Disease.- Clinical Applicability of the Determination of Erythropoietin.- A Sensitive ELISA for Erythropoietin and Its Application in Various Diseases.- Use of Erythropoietin Radioimmunoassay in Polycythemias.- Effects of Exercise on Plasma Erythropoietin in Natives Living Permanently at High Altitude.- Erythropoietin Concentration in Renal Venous Blood in Patient with Renovascular Hypertension: Is It a Marker of Renal Ischemia.- Serum Erythropoietin Levels in Von Hippel-Lindau Syndrome.- IV. Erythropoietin Replacement in Renal Failure.- Iron Metabolism Under Treatment of Renal Anemia with Recombinant Human Erythropoietin.- Erythropoietin Treatment in Children with Renal Anemia.- Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1, 25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies.- Dyserythropoietic Abnormalities in Hemodialysis Patients on Long-Term Therapy with Human Recombinant Erythropoietin.- Cardiological Findings in Patients with End-Stage Renal Failure Under Treatment with Erythropoietin.- Long-Term Treatment with Recombinant Human Erythropoietin in Haemodialysis Patients: Effects on Left Ventricular Performance.- Retinal Hypoxia and Anemia in Chronic Renal Failure: Effect of Erythropoietin.- Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients.- Pharmacodynamic Aspects of Recombinant Human Erythropoietin - Long-Term Results in Patients with Hemodialysis Treatment.- Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells.- Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin.- V. Primary Hemopoietic Disorders and Chemotherapy.- Serum Erythropoietin Levels in Aplastic Anemia Determined by ELISA.- Serum Erythropoietin in Myelodysplasia Syndromes.- Antigenic Characteristics of Erythropoietin-Dependent and -Independent Erythroid Progenitors in Chronic Myeloproliferative Disorders Defined by Monoclonal Antibodies.- Chemotherapy and Erythropoietin Production.- Production of Erythropoietin During and After Thiamphenicol Treatment Occurs Independently of Peripheral Blood Cell Numbers.- VI. Application of Recombinant Erythropoietin in Non-Renal Anemia.- Effects of Inflammatory Cytokines on the Production of Erythropoietin.- The Use of Recombinant Human Erythropoietin in the Treatment of the Anemia of Chronic Disorders.- Recombinant Human Erythropoietin in the Treatment of Anaemia in Rheumatoid Arthritis.- Erythropoietin in Neoplastic Diseases: Preliminary Results.- Erythropoietin Effects on Acute Anemia Induced by Antineoplastic Therapy in the Case of a Uremic Patient with Lymphoma.- The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplasia Syndromes.- The Effect of Erythropoietin in Chemotherapy-Induced Anaemia in Patients with Osteosarcoma and Ewing's Sarcoma.- Erythropoietin in Bone Marrow Transplantation: Pathophysiology and Clinical Use.- Experimental and Clinical Results of Perioperative Treatment with Recombinant Human Erythropoietin.

Erscheint lt. Verlag 24.11.2011
Zusatzinfo XVI, 328 p.
Verlagsort Berlin
Sprache englisch
Maße 155 x 235 mm
Gewicht 527 g
Themenwelt Studium 1. Studienabschnitt (Vorklinik) Physiologie
Naturwissenschaften Biologie
Schlagworte Anaämie • anemia • Cytokine • cytokines • Erythropoietin • Niereninsuffizienz • pathophysiology • Physiology • Renal failure
ISBN-10 3-642-77076-2 / 3642770762
ISBN-13 978-3-642-77076-0 / 9783642770760
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hans-Christian Pape; Armin Kurtz; Stefan Silbernagl

Buch (2023)
Thieme (Verlag)
CHF 153,95
Lehrbuch

von Erwin-Josef Speckmann; Jürgen Hescheler …

Buch | Hardcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60